A million young people will be offered the meningitis B vaccine after a deadly outbreak in the UK / Image – File
The meningitis B (MenB) vaccine will be offered to around a million young people across the UK under a major new NHS program launched in response to a series of outbreaks that have claimed lives and raised concerns among health officials.The one-off vaccination campaign will target Year 13 students and young people under the age of 25 who are due to start university or residential education this autumn. Health authorities say the move aims to protect those most at risk as they prepare to enter environments where the disease can spread more easily through close contact.The announcement follows a number of MenB outbreaks this year, including a major cluster in Kent which has become the largest and fastest spread of its kind recorded in the UK.
The outbreak has led to two deaths and more than 20 confirmed cases, while additional clusters have since been reported in areas including Reading and Dorset.
Meningitis B vaccines in the United Kingdom
The government’s decision follows health experts identifying an increased risk of MenB infection among older teenagers and young adults, especially those moving into university halls, shared accommodation and other residential settings.Close social contact is known to increase the risk of transmission of meningococcal disease, making first-year college students one of the most vulnerable groups.
According to the UK Health Security Agency (UKHSA), the risk of MenB infection among first-year university students is much higher than among young people who do not go to university.Health Minister James Murray said the recent outbreak may signal a change in how the disease affects young people. He said the government was acting immediately to protect those most at risk while reviewing longer-term evidence.
Eligibility for MenB vaccine
Under the scheme, all Year 13 pupils in England, along with young people under 25 starting university or further residential education for the first time this autumn, will be eligible.The offer will include international students under the age of 25 starting their studies in the UK. Eligible students will receive two doses of the MenB vaccine, known as Bexsero, made by GSK. Doses must be taken at least 28 days apart to provide full protection.The first vaccinations will begin from July 20, with second doses scheduled to begin in August. Students who travel during summer break will still be able to receive their second dose in September. Eligible young people will be contacted through the NHS app, texts, emails or letters, while others may be able to book appointments directly through participating pharmacies.
Meningitis B cases across the UK
B meningitis is caused by group B meningococcal bacteria and can lead to life-threatening illnesses including meningitis (inflammation of the protective membranes around the brain and spinal cord) and septicemia (severe blood infection that can develop into sepsis).Symptoms can develop rapidly and may include fever, severe headache, vomiting, drowsiness, sensitivity to light, breathing difficulties, and a characteristic skin rash that does not fade under stress. Even with treatment, the disease can cause permanent disability, neurological damage or death.Although the UK has routinely vaccinated children against MenB since 2015, most teenagers and young adults were too old to receive the vaccine as part of the childhood programme, leaving a large population without direct protection against this strain.The vaccination program follows intense scrutiny of the UK’s MenB strategy following an outbreak in Kent earlier this year.Health officials described the Kent cluster as unprecedented because of the speed with which cases emerged. More than 20 cases were linked to the disease, while two young men died after contracting the disease. The outbreak has prompted emergency vaccination campaigns, distribution of antibiotics, and calls from affected families for wider access to the MenB vaccine.Among the victims was 18-year-old Juliet Kenny, whose family later campaigned for wider vaccination coverage for teenagers and young adults. The outbreak has also raised renewed questions about whether the MenB vaccine should become part of the routine immunization program for adolescents.More clusters of MenB have since been recorded in Dorset and Reading, raising concerns among public health officials that young people may face increased risks of the disease.
Looking forward
The new rollout is currently a one-off emergency program and not a permanent expansion of NHS vaccination schedules.However, the Joint Committee on Vaccination and Immunization (JCVI) is reviewing the latest evidence and is expected to advise ministers on whether a wider, longer-term vaccination program for teenagers should be offered.For now, health officials are urging eligible students to apply for both doses before the start of the school year, warning that early protection can help prevent further outbreaks when meningococcal disease typically peaks during the fall months.
